Shares of Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) saw strong trading volume on Tuesday . 168,539 shares traded hands during trading, an increase of 147% from the previous session’s volume of 68,333 shares.The stock last traded at $13.70 and had previously closed at $14.1250.
Analyst Upgrades and Downgrades
Separately, Citigroup downgraded Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Monday, January 26th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $32.20.
Get Our Latest Research Report on SKHHY
Sonic Healthcare Stock Down 3.0%
Sonic Healthcare Company Profile
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Further Reading
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
